 Navin Fluorine International Ltd approves capex
Navin Fluorine International Ltd approves capex Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart
Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets
Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets IPO Note - Lenskart Solutions Ltd - Reliance Securities
IPO Note - Lenskart Solutions Ltd - Reliance Securities IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025
IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025 
              SBI Funds Management Pvt Ltd has announced that SBI Mutual Fund, through various schemes has sold 30000 shares of Dr. Lal PathLabs Ltd, representing 0.0360% of the paid up share capital of the company on March 14, 2018.
The final holding of SBI Mutual Fund, through various schemes was 30,45,089 equity shares which is 3.6541% of the paid up share capital of the company.
Prior to the sale, the fund had 3,075,089 equity shares or 3.6901% stake in the company.
Shares of Dr. Lal PathLabs Ltd was last trading in BSE at Rs.898 as compared to the previous close of Rs. 888.75. The total number of shares traded during the day was 2020 in over 115 trades.
The stock hit an intraday high of Rs. 901.1 and intraday low of 874. The net turnover during the day was Rs. 1791331.